June 1-3, 2024
China Import and Export Fair Complex, Guangzhou, China
ORGANIZATION
China Association for Science and Technology (CAS) Consortium of Life Sciences Societies (proposed)
INTRODUCTION
2024 China Life Science Conference and China Life Science Expo (CILSE) has gradually become a high-level and far-reaching brand event in the life science field in China and even the world due to its high-level conference specifications, large scale, stronger academic leadership, and closer integration with industry. In order to further leverage the academic value and influence of the “2024 China Life Science Conference” and strengthen international academic exchanges and cooperation in the field of life science and health, the keynote report of the conference plans to invite dozens of academicians, experts, professors and international leaders in the field of life science to give keynote reports, and hold dozens of thematic sub-forums around the future development of life science. The exhibition will focus on showing the strength and innovative achievements of scientists in the field of life science, using the new model of “academic conference + exhibition”, focusing on molecular diagnostics, antibody drugs, cell and gene therapy, mRNA, epigenetics, single cell, multi-omics, biological big data, vaccines, antibodies, exosomes, tumor early screening, tumor detection, organ transplantation and other fields, promoting multidisciplinary cross-cutting development and promoting exchanges and cooperation between upstream and downstream industries.
[SCALE]
- 10+ academicians of the Chinese Academy of Sciences and Chinese Academy of Engineering
- 30+ forums
- 20,000+ professional visitors
- 50,000 square meters of exhibition hall area
EXPO SCOPE
Laboratory equipment, biochemical instruments, general equipment, reagents/consumables, biotechnology and R&D services, biological process engineering, laboratory animals, synthetic biology, biological products, medical testing and IVD, biopharmaceuticals, omics technology, bioinformatics and artificial intelligence, industrial parks, etc.
